Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-06
2005-09-06
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S347000, C514S358000
Reexamination Certificate
active
06939885
ABSTRACT:
Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
REFERENCES:
patent: 2997368 (1961-08-01), Barent et al.
patent: 4166452 (1979-09-01), Generales, Jr.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4954518 (1990-09-01), Takano et al.
patent: 4992091 (1991-02-01), Vinogradoff et al.
patent: 4997940 (1991-03-01), Vinogradoff et al.
patent: 5021591 (1991-06-01), Vinogradoff et al.
patent: 5071468 (1991-12-01), Astles et al.
patent: 5093364 (1992-03-01), Richards et al.
patent: 5155121 (1992-10-01), Niewohner
patent: 5163995 (1992-11-01), Van Heertum
patent: 5185348 (1993-02-01), Niewohner et al.
patent: 5217521 (1993-06-01), Durr
patent: 5481005 (1996-01-01), Wagnon et al.
patent: 5541186 (1996-07-01), Breu et al.
patent: 5571775 (1996-11-01), Van Heertum et al.
patent: 5589478 (1996-12-01), Yamada et al.
patent: 5780488 (1998-07-01), Bergman et al.
patent: 5973148 (1999-10-01), Ringer et al.
patent: 6136971 (2000-10-01), Harrington et al.
patent: 6200995 (2001-03-01), De la Brouse-Elwood et al.
patent: 6297195 (2001-10-01), Gesing et al.
patent: 6297239 (2001-10-01), deSolms et al.
patent: 6316450 (2001-11-01), Bromidge et al.
patent: 6432624 (2002-08-01), Kikuchi et al.
patent: 2002/0009116 (2002-01-01), Kobayashi et al.
patent: 2002/0012680 (2002-01-01), Patel
patent: 2002/0013314 (2002-01-01), Zhu et al.
patent: 2002/0037905 (2002-03-01), Dahl
patent: 2002/0037928 (2002-03-01), Jaen et al.
patent: 2002/0065303 (2002-05-01), Zhu et al.
patent: 2002/0072530 (2002-06-01), Zhu et al .
patent: 2002/0103202 (2002-08-01), Pinto
patent: 2003/0060460 (2003-03-01), Ohuchida et al.
patent: 2003/0139390 (2003-07-01), McGee et al.
patent: 561703 (1975-05-01), None
patent: 3825041 (1990-02-01), None
patent: 556673 (1993-02-01), None
patent: 884847 (1961-12-01), None
patent: 1332697 (1973-10-01), None
patent: WO 94/20142 (1994-09-01), None
patent: WO 95/33462 (1995-12-01), None
patent: WO 96/08483 (1996-03-01), None
patent: WO 98/11218 (1998-03-01), None
patent: WO 98/28270 (1998-07-01), None
patent: WO 98/50029 (1998-11-01), None
patent: WO 99/17777 (1999-04-01), None
patent: WO 99/38845 (1999-08-01), None
patent: WOI-99/38845 (1999-08-01), None
patent: WO 99/42465 (1999-08-01), None
patent: WO 99/55663 (1999-11-01), None
patent: WO 00/05214 (2000-02-01), None
patent: WO 00/62778 (2000-10-01), None
patent: WO 01/00579 (2001-01-01), None
patent: WO 01/09097 (2001-02-01), None
patent: WO 01/17971 (2001-03-01), None
patent: WO 01/19788 (2001-03-01), None
patent: WO 01/19798 (2001-03-01), None
patent: WO 01/32646 (2001-05-01), None
patent: WO 01/56607 (2001-08-01), None
patent: WO 01/56989 (2001-08-01), None
patent: WO 01/57003 (2001-08-01), None
patent: WO 01/57020 (2001-08-01), None
patent: WO 01/60319 (2001-08-01), None
patent: WO 02/00633 (2002-01-01), None
patent: WO 02/30358 (2002-04-01), None
patent: WO 02/54867 (2002-07-01), None
patent: WO 02/55501 (2002-07-01), None
patent: WO 02/59080 (2002-08-01), None
patent: WO 03/99773 (2003-12-01), None
Berman et al., Immunol.Invest., 17, pp. 625-677, 1988.
Campbell, et al.,J. Exp. med., 195(1), pp. 135-141, 2002.
Dahinden, et al.,J. Exp. Med., 179, pp. 751-756, 1994.
Dannhardt, et. al., 37Eur.J.Med.Chem., pp. 147-161, 2002.
Davidson et al.,J Exp med., 184, pp. 241-251, 1996.
Kavanaugh et al.,J. Immunol., 146, pp. 4149-4156, 1991.
Kontoyiannis et al.,Immunity, 10, pp. 387-398, 1999.
Kosiewicz et al.,J Clin Invest., 107(6), pp. 695-702, 2001.
Kunkel, et al.,J. Exp. med., 192(5), pp. 761-767, 2000.
Lothrop et al.,J.Amer.Chem.Coc., CODEN;JACSAT, 63, pp. 2564-2567, 1941.
Murphy,Rev. Immun., 12, pp. 593-633, 1994.
Neote, et al.,Cell, 72, pp. 415-425, 1993.
Panwala, et al.,J Immunol., 161, pp. 5733-44, 1998.
Papadakis, et al.,J. Immunol., 165, pp. 5069-5076, 2000.
Powrie et al.,Int Immunol., 5(11), pp. 1461-71, 1993.
Qiuping Z et al.,Cancer Res., 63, pp. 6469-77, 2003.
Schaarschmidt; Herzenberg, ChemBer., CODEN;CHBEAM, 53, pp. 1388-1399, 1920.
Schall,Cytokine, 3, pp. 165-183, 1991.
Schall, et al.,Curr. Opin. Immunol., 6, pp. 865-873, 1994.
SciFinder Search Results (Feb. 19, 2004).
SciFinder Search Results (Feb. 20, 2004).
Silvestri et al.,Medicinal Chemistry Research, 11(4), pp. 195-218, 2002.
Street et.al., Journal of Chemical Research, Synopses, (5), pp. 154-55, 1987.
Targan et al.,N Engl J Med., 337(15), pp. 1029-35, 1997.
Uehara, et al.,J. Immunol, 168(6), pp. 2811-2819, 2002.
Ullmann; Bleier, Chem.Ber., CODEN;CHBEAM, 35, pp. 4273-4280, 1902.
Van Riper, et al.,J. Exp. Med., 177, pp. 851-856, 1993.
Wurbel, et al.,Blood, 98(9), pp. 2626-2632, 2001.
Youn BS, et al., Apoptosis, 7, pp. 271-276, 2002.
Zaballos, et al.,J. Immunol., 162, pp. 5671-5675, 1999.
Pennell Andrew
Ungashe Solomon
Wei Zheng
Wright John Jessen
Brinks Hofer Gilson & Lione
Chemocentryx
Coppins Janet L.
McKane Joseph K.
LandOfFree
Aryl sulfonamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl sulfonamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl sulfonamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3378694